Hyperprolactinemia differential diagnosis: Difference between revisions
Kiran Singh (talk | contribs) |
No edit summary |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hyperprolactinemia}} | {{Hyperprolactinemia}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
Hyperprolactinemia must be differentiated from other diseases that cause [[virilization]] and [[hirsutism]] in female. The differentials include [[21-hydroxylase deficiency]], [[17 alpha-hydroxylase deficiency|17-alpha hydroxylase deficiency]], [[11β-hydroxylase deficiency|11-β hydroxylase deficiency]], [[3 beta-hydroxysteroid dehydrogenase deficiency]], [[Polycystic ovary syndrome|polycystic ovarian syndrome]], [[Adrenal Gland|adrenal]] tumors, [[ovarian]] [[Virilization|virilizing]] [[tumors]] and [[cushing's syndrome]]. | |||
==Differential Diagnosis== | |||
'''Differentials based on virilization and hirsutism''' | |||
Hyperprolactinemia must be differentiated from diseases that cause [[virilization]] and [[hirsutism]] in female:<ref name="pmid24830586">{{cite journal |vauthors=Hohl A, Ronsoni MF, Oliveira Md |title=Hirsutism: diagnosis and treatment |journal=Arq Bras Endocrinol Metabol |volume=58 |issue=2 |pages=97–107 |year=2014 |pmid=24830586 |doi= |url=}}</ref><ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref><ref name="ISBN:978-0323297387">{{cite book | last = Melmed | first = Shlomo | title = Williams textbook of endocrinology | publisher = Elsevier | location = Philadelphia, PA | year = 2016 | isbn = 978-0323297387 }}=</ref> | |||
{| class="wikitable" | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Steroid status | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other laboratory | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Important clinical findings | |||
|- | |||
|Non-classic type of [[21-hydroxylase deficiency]] | |||
|Increased: | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | |||
* Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] in response to [[ACTH]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* No symptoms in infancy and male | |||
* [[Virilization]] in females | |||
|- | |||
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | |||
|Increased: | |||
* DOC | |||
* 11-Deoxy-[[Cortisol]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Hypertension]] and [[hypokalemia]] | |||
* [[Virilization]] | |||
|- | |||
|[[3 beta-hydroxysteroid dehydrogenase deficiency]] | |||
|Increased: | |||
* [[DHEA]] | |||
* [[17-hydroxypregnenolone]] | |||
* [[Pregnenolone]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* Salt-wasting [[adrenal crisis]] in infancy | |||
* Mild [[virilization]] of genetically female infants | |||
* [[Undervirilization]] of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | |||
|- | |||
|[[Polycystic ovary syndrome ]] | |||
| | |||
* High [[DHEAS]] and [[androstenedione]] levels | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Polycystic ovaries]] in sonography | |||
* [[Obesity]] | |||
* [[PCOS]] is the most common cause of [[hirsutism]] in women | |||
* No evidence another diagnosis | |||
|- | |||
|[[Adrenal tumors]] | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* Low [[testosterone]] level | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
|Ovarian [[virilizing]] tumor | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* [[Testosterone]] is high | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
|[[Cushing's syndrome]] | |||
| | |||
* Increase [[cortisol]] & metabolites | |||
* Variable other [[steroids]] | |||
| | |||
* Variable [[mineralocorticoid]] excess | |||
| | |||
* [[Cushingoid appearance]] | |||
|- | |||
|[[Hyperprolactinemia]] | |||
| | |||
* Normal levels of most of [[steroids]] | |||
| | |||
* Increased [[prolactin]] | |||
| | |||
* [[Infertility]], [[galactorrhea]] | |||
|} | |||
=== Differentials based on irregular menstruation and hirsutism === | |||
Hyperprolactinemia must be differentiated from other causes of irregular [[Menstruation|menses]] and [[hirsutism]], The differentials include the following: | |||
{| class="wikitable" | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Differentiating Features | |||
|- | |||
|[[Pregnancy]] | |||
| | |||
* Pregnancy always should be excluded in a patient with a history of amenorrhea | |||
* Features include amenorrhea or oligomenorrhea, abnormal uterine bleeding, nausea/vomiting, cravings, weight gain (although not in the early stages and not if vomiting), polyuria, abdominal cramps and constipation, fatigue, dizziness/lightheadedness, and increased pigmentation (moles, nipples) | |||
* Uterine enlargement is detectable on abdominal examination at approximately 14 weeks of gestation | |||
* Ectopic pregnancy may cause oligomenorrhea, amenorrhea, or abnormal uterine bleeding with abdominal pain and sometimes subtle or absent physical symptoms and signs of pregnancy | |||
|- | |||
|Hypothalamic amenorrhea | |||
| | |||
* Diagnosis of exclusion | |||
* Seen in athletes, people on crash diets, patients with significant systemic illness, and those experiencing undue stress or anxiety | |||
* Predisposing features are as follows weight loss, particularly if features of anorexia nervosa are present or the BMI is <19 kg/m2 | |||
* Recent administration of depot medroxyprogesterone, which may suppress ovarian activity for 6 months to a year | |||
* Use of dopamine agonists (eg, antidepressants) and major tranquilizers | |||
* Hyperthyroidism | |||
* In patients with weight loss related to anorexia nervosa, fine hair growth (lanugo) may occur all over the body, but it differs from hirsutism in its fineness and wide distribution | |||
|- | |||
|[[Primary amenorrhea]] | |||
| | |||
* Causes include reproductive system abnormalities, chromosomal abnormalities, or delayed puberty | |||
* If secondary sexual characteristics are present, an anatomic abnormality (eg, imperforate hymen, which is rare) should be considered | |||
* If secondary sexual characteristics are absent, a chromosomal abnormality (eg, Turner syndrome ) or delayed puberty should be considered | |||
|- | |||
|[[Cushing's syndrome|Cushing syndrome]] | |||
| | |||
* Cushing syndrome is due to excessive glucocorticoid secretion from the adrenal glands, either primarily or secondary to stimulation from pituitary or ectopic hormones; can also be caused by exogenous steroid use | |||
* Features include hypertension, weight gain (central distribution), acne, and abdominal striae Patients have low plasma sodium levels and elevated plasma cortisol levels on dexamethasone suppression testing | |||
|- | |||
|[[Hyperprolactinemia]] | |||
| | |||
* Mild hyperprolactinemia may occur as part of PCOS-related hormonal dysfunction | |||
* Other causes include stress, lactation, and use of dopamine antagonists | |||
* A prolactinoma of the pituitary gland is an uncommon cause and should be suspected if prolactin levels are very high (>200 ng/mL) | |||
* Physical examination findings are usually normal | |||
* As in patients with PCOS, hyperprolactinemia may be associated with mild galactorrhea and oligomenorrhea or amenorrhea; however, galactorrhea also can occur with nipple stimulation and/or stress when prolactin levels are within normal ranges | |||
* A large prolactinoma may cause headaches and visual field disturbance due to pressure on the optic chiasm, classically a gradually increasing bi-temporal hemianopsia | |||
|- | |||
|Ovarian or adrenal tumor | |||
| | |||
* Benign ovarian tumors and ovarian cancer are rare causes of excessive androgen secretion; adrenocortical tumors also can increase the production of sex hormones | |||
* Abdominal swelling or mass, abdominal pain due to fluid leakage or torsion, dyspareunia, abdominal ascites, and features of metastatic disease may be present | |||
* Features of androgenization include hirsutism, weight gain, oligomenorrhea or amenorrhea, acne, clitoral hypertrophy, deepening of the voice, and high serum androgen (eg, testosterone, other androgens) levels | |||
* In patients with an androgen-secreting tumor, serum testosterone is not suppressed by dexamethasone | |||
|- | |||
|[[Congenital adrenal hyperplasia]] | |||
| | |||
* Congenital adrenal hyperplasia is a rare genetic condition resulting from 21-hydroxylase deficiency | |||
* The late-onset form presents at or around menarche Patients have features of androgenization and subfertility | |||
* Affects approximately 1% of hirsute patients More common in Ashkenazi Jews (19%), inhabitants of the former Yugoslavia (12%), and Italians (6%) | |||
* Associated with high levels of 17-hydroxyprogesterone | |||
* A short adrenocorticotropic hormone stimulation test with measurement of serum17-hydroxyprogesterone confirms the diagnosis Assays of a variety of androgenic hormones help define other rare adrenal enzyme deficiencies, which present similarly to 21-hydroxylase deficiency | |||
|- | |||
|Anabolic steroid abuse | |||
| | |||
* Anabolic steroids are synthetic hormones that imitate the actions of testosterone by increasing muscle bulk and strength | |||
* Should be considered if the patient is a serious sportswoman or bodybuilder | |||
* Features include virilization (including acne and hirsutism), often increased muscle bulk in male pattern, oligomenorrhea or amenorrhea, clitoromegaly, gastritis, hepatic enlargement, alopecia, and aggression | |||
* Altered liver function test results are seen | |||
|- | |||
|[[Hirsutism]] | |||
| | |||
* Hirsutism is excessive facial and body hair, usually coarse and in a male pattern of distribution | |||
* Approximately 10% of women report unwanted facial hair | |||
* There is often a family history and typically some Mediterranean or Middle Eastern ancestry | |||
* May also result from use of certain medications, both androgens, and others including danazol, glucocorticoids, cyclosporine, and phenytoin | |||
* Menstrual history is normal | |||
* When the cause is genetic, the excessive hair, especially on the face (upper lip), is present throughout adulthood, and there is no virilization | |||
* When secondary to medications, the excessive hair is of new onset, and other features of virilization, such as acne and deepened voice, may be present | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Needs content]] | |||
[[Category:Needs | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
{{WS}} | |||
{{WH}} |
Latest revision as of 15:14, 6 November 2017
Hyperprolactinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyperprolactinemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Hyperprolactinemia differential diagnosis |
Risk calculators and risk factors for Hyperprolactinemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Hyperprolactinemia must be differentiated from other diseases that cause virilization and hirsutism in female. The differentials include 21-hydroxylase deficiency, 17-alpha hydroxylase deficiency, 11-β hydroxylase deficiency, 3 beta-hydroxysteroid dehydrogenase deficiency, polycystic ovarian syndrome, adrenal tumors, ovarian virilizing tumors and cushing's syndrome.
Differential Diagnosis
Differentials based on virilization and hirsutism
Hyperprolactinemia must be differentiated from diseases that cause virilization and hirsutism in female:[1][2][3]
Disease name | Steroid status | Other laboratory | Important clinical findings |
---|---|---|---|
Non-classic type of 21-hydroxylase deficiency | Increased:
|
|
|
11-β hydroxylase deficiency | Increased:
Decreased: |
|
|
3 beta-hydroxysteroid dehydrogenase deficiency | Increased:
Decreased: |
|
|
Polycystic ovary syndrome |
|
|
|
Adrenal tumors |
|
|
|
Ovarian virilizing tumor |
|
|
|
Cushing's syndrome |
|
||
Hyperprolactinemia |
|
|
Differentials based on irregular menstruation and hirsutism
Hyperprolactinemia must be differentiated from other causes of irregular menses and hirsutism, The differentials include the following:
Disease | Differentiating Features |
---|---|
Pregnancy |
|
Hypothalamic amenorrhea |
|
Primary amenorrhea |
|
Cushing syndrome |
|
Hyperprolactinemia |
|
Ovarian or adrenal tumor |
|
Congenital adrenal hyperplasia |
|
Anabolic steroid abuse |
|
Hirsutism |
|
References
- ↑ Hohl A, Ronsoni MF, Oliveira M (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586. Vancouver style error: initials (help)
- ↑ White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=